Explore the full record of transactions filed by Bolzon Bradley J PhD, Director. Director active across 2 companies, notably CRISPR Therapeutics AG. In total, 10 filings have been logged. Total volume traded: €2.7m. The latest transaction was filed on 19 July 2021 — Cession. Regulator: SEC (Form 4). All data is free.
Bradley J. Bolzon, PhD, serves as a Director at CRISPR Therapeutics AG and Monte Rosa Therapeutics, Inc. He plays a key role in the governance of these companies and in shaping their strategy. His expertise in biotechnology is an asset to the board.